Cargando…
Novel 8-Methoxycoumarin-3-Carboxamides with potent anticancer activity against liver cancer via targeting caspase-3/7 and β-tubulin polymerization
In the present study, we explored the potential of coumarin-based compounds, known for their potent anticancer properties, by designing and synthesizing a novel category of 8-methoxycoumarin-3-carboxamides. Our aim was to investigate their antiproliferative activity against liver cancer cells. Towar...
Autores principales: | Alzamami, Ahmad, Radwan, Eman M., Abo-Elabass, Eman, Behery, Mohammed El, Alshwyeh, Hussah Abdullah, Al-Olayan, Ebtesam, Altamimi, Abdulmalik S., Attallah, Nashwah G. M., Altwaijry, Najla, Jaremko, Mariusz, Saied, Essa M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693084/ https://www.ncbi.nlm.nih.gov/pubmed/38041156 http://dx.doi.org/10.1186/s13065-023-01063-5 |
Ejemplares similares
-
Unveiling the antitumor potential of novel N-(substituted-phenyl)-8-methoxycoumarin-3-carboxamides as dual inhibitors of VEGFR2 kinase and cytochrome P450 for targeted treatment of hepatocellular carcinoma
por: Radwan, Eman M., et al.
Publicado: (2023) -
Novel 2-substituted-quinoxaline analogs with potential antiproliferative activity against breast cancer: insights into cell cycle arrest, topoisomerase II, and EGFR activity
por: Salem, Manar G., et al.
Publicado: (2023) -
Novel Exopolysaccharide from Marine Bacillus subtilis with Broad Potential Biological Activities: Insights into Antioxidant, Anti-Inflammatory, Cytotoxicity, and Anti-Alzheimer Activity
por: Abdel-Wahab, Basel A., et al.
Publicado: (2022) -
Design and Synthesis of New Thiophene/Thieno[2,3-d]pyrimidines along with Their Cytotoxic Biological Evaluation as Tyrosine Kinase Inhibitors in Addition to Their Apoptotic and Autophagic Induction
por: Elmongy, Elshaymaa I., et al.
Publicado: (2021) -
In-Silico Screening of Novel Synthesized Thienopyrimidines Targeting Fms Related Receptor Tyrosine Kinase-3 and Their In-Vitro Biological Evaluation
por: Elmongy, Elshaymaa I., et al.
Publicado: (2022)